Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference
LEXINGTON, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...